Abbreviations: ICM = iodinated contrast media DEFICM = Dose enhancement factor due to ICM
Introduction:
Iodinated contrast media (ICM) are frequently used in diagnostic x-ray imaging, including around 50% of CT scans [1] , to improve visualization of blood vessels and other structures. In addition to well-known chemo/osmotoxic side effects, including allergic reactions and kidney damage [2] , concerns have also been raised that contrast media may increase cancer risks from x-ray exposures [3, 4] . Recently, we reviewed around four decades-worth of research investigating the radiation doses and associated DNA damage for ICM-enhanced, versus unenhanced x-ray exposures [5] . Increased DNA damage is likely to be a dosimetric effect, due to ICM molecules acting as a source of secondary radiation, i.e. photoelectrons, Auger electrons and photons. To date, all DNA damage assays have focused on cells in the blood itself, i.e. lymphocytes. While a clear suggestion of increased blood cell DNA damage for ICM-enhanced exposures was apparent (typically 30-100%, though up to 267%), it is unclear if these findings also imply an increased risk of developing cancer. In particular, it is not clear if the presence of iodine in blood vessels leads to DNA damage in extravascular cells, including those cells prone to malignant transformation.
Few studies investigating the dosimetric impact of ICM on tissues other than the blood in diagnostic x-ray imaging have been published [6] [7] [8] [9] [10] . These have generally focused on macroscopic doses, i.e. the mean absorbed dose to whole organs or phantoms, without assessing the microscopic pattern of energy deposition under ICM-enhanced conditions. As the dose perturbation effects of high Z elements are extremely close range (typically within a few tens of micrometres) [11] , it may be possible for ICM to increase blood dose and macroscopic organ doses quite markedly with little impact on dose to cells outside blood vessels. To investigate this, and to help place blood cell DNA damage assays in context, we performed a microdosimetric analysis using the Monte Carlo code MCNP6.1 and two simple blood vessel models. The aim of the study was to investigate ICMassociated enhancement of dose as a function of distance from the blood itself, for various concentrations of iodine in the blood and various beam spectra used in clinical x-ray imaging.
Methods:
Three models were constructed. The first represented a single 5 cm long artery ( Figure 1 ) with radial dimensions typical of a coronary artery in a normal individual, based on previously published data [12] [13] [14] . The radius of the artery lumen was initially set at 2000 μm. The wall was divided into three anatomical layers, or 'tunicas', namely the intima (150 μm thick), media (200 μm) and adventitia (400 μm) [13] , giving a total wall thickness of 750 μm [14] . To examine the dose distribution within the intima in detail, the first 10 μm of this layer was divided into concentric layers of 1 μm thickness. The innermost of these layers thus represented the single-cell-thick endothelium of blood vessels. The following 10 μm (i.e. 10-20 μm from the lumen edge) was divided into 2 μm layers and the next 30 μm (20-50 μm from the lumen edge) was divided into 10 μm layers.
Each layer of the vessel wall was composed of 'ICRP' 13-element soft tissue material (density, ρ = 1.00 g/cm 3 ) obtained from the National Institute of Standards and Technology [15] , except for the media, which was composed of ICRP muscle (ρ = 1.04 g/cm 3 ) . The lumen was filled with ICRP 13-element blood material (ρ = 1.06 g/cm 3 ), combined with different mass concentrations of iodine (ρiI) (0, 5, 10, 50 and 100 mg I/ml). The density of the blood was adjusted to correspond to ρiI. The vessel was placed within a larger soft tissue cylinder of radius 10 cm to simulate electron build-up, scattering and beam hardening effects that would occur for vessels located deep within the body. A sensitivity analysis was performed by removing the build-up cylinder. Simulations were also repeated with different lumen radii (1000 and 4000 μm).
The second model represented multiple capillaries within a small block of soft tissue ( Figure 2 ). This was based around a 25 x 25 lattice of 40 x 40 x 100 μm cuboid elements, each containing a 'capillary' composed of ICRP blood material, of radius 5 μm and length 100 μm, surrounded by five concentric 1 μm thick layers of ICRP soft tissue (cells A-E in Figure 2 ). The innermost of these layers was considered representative of the capillary wall. The extravascular remainder of each lattice element was also composed of ICRP soft tissue. As with the artery model, the lattice was placed within a soft tissue cylinder of radius 10 cm. The model was designed to represent a typical soft tissue with average capillary density. The distance between the edges of adjacent capillary lumens ranged from 30 μm to 47 μm. Blood made up 5% of the total volume of each lattice element.
A modified version of the capillary model was also produced, representing a more densely perfused tissue ( Figure 3 ). In this model, the lattice elements were reduced in size to 20 x 20 x 100 μm, while the capillaries were maintained at the same size. The distance between the edges of adjacent capillary lumens in the dense model ranged from 10 μm to 18 μm, with blood making up 20% of the volume of each lattice element. Sensitivity analyses were performed by adjusting the density of soft tissue in regions B, C, D, E, F and G in the standard capillary model to 0.5 and 2.0 g/cm 3 (i.e. half and twice the normal density) and changing the composition from soft tissue to adipose (fat, ρ= 0.92 g/cm 3 ) and cortical bone (ρ= 1.85 g/cm 3 ). In each case, the composition of the blood and the vessel wall (region A) were left unchanged.
The third model ( Figure 4 ) was designed to simulate situations in which ICM has been given sufficient time to diffuse through capillary walls and reach the interstitial medium of a tissue at the time of exposure. With the exception of hepatocytes, ICM are not thought to be able to enter cells themselves. The interstitial model comprised a 50 x 50 x 50 lattice of cubes, each 11 x 11 x 11 μm in size, containing a single cell with a nucleus of radius 7 μm (thus larger than the lattice element, creating 'squircle'-like cell shapes). The remainder of each lattice element (C in figure 4 ) was water, combined with mass concentrations of 0, 1 and 5 mg I/ml of iodine. 
Monte Carlo simulation methodology:
We used the general purpose Monte Carlo code MCNP6.1 (Los Alamos National Laboratory, New
Mexico, USA) [16] for simulations. MCNP has an energy cut-off value of 1 eV. For both the models described above, an x-ray source was placed 15 cm away from the centre of the artery/lattice, thus to 2000 for all regions except the build-up cylinder, which was left at 3.
Beam spectra, representing four clinical applications (two cardiac fluoroscopy and two computed tomography), were produced using Spekcalc [17] , Figures showing these beam spectra are presented as supplementary materials for this paper. The energy imparted (ε) to the blood itself and each region of the vessel wall, was tallied. Absorbed dose was calculated by dividing ε by the mass of the respective cell. The dose enhancement factor (DEFICM), presented as percentage increase, was calculated as:
Where DI is the absorbed dose in the presence of iodine in the blood and DNo I is the dose in the absence of iodine. The number of physical events by photoelectric absorption, Compton scattering and generation of knock-on electrons (delta rays) in each region, was also recorded to aid interpretation of the results and understanding of the underlying physics.
Results:
For the artery model, the absorbed dose to the blood itself was increased with the presence of iodine (Table 1 , Figure 4 ). Averaged over the four beam spectra, DEFICM was 1.70, 2.38, 7.38 and 12.34, for ρiI levels of 5, 10, 50 and 100 mg/ml, respectively. Mean MC simulation uncertainties for the blood region were 0.11% (max: 0.15%). Dose was also increased in the vessel wall, albeit to a much smaller extent. Within the first micrometre of the wall, i.e. the region representing the endothelium, average DEFICM was 1.26, 1.51, 3.48 and 5.56, for the same respective ρiI levels. Mean simulation uncertainties for the 1 μm thick layers were 2.37% (max: 3.18%). There was no suggestion of any ICM-associated increase in dose outside the media, i.e. >150 μm from the lumen edge. Compared to iodine concentration, x-ray beam spectra had relatively little impact (Table 1, Figure 5 ). The ratio of maximum/minimum DEFICM for the four spectra was approximately 2, compared to a factor of over 10 for different iodine concentrations. The greatest increase in DEFICM to the blood itself was found for Spectrum 2 (80 kV, 0.6 mm Cu) while the smallest increase was found for Spectrum 1 (120 kV, 0.2 mm Cu). These differences probably being caused by the lower photoelectric absorption cross section for the higher energy photons and longer ranges of the secondary electrons produced. Beyond around 8 μm from the lumen edge, Spectrum 1 tended to yield a marginally higher DEFICM than the other three spectra, also confirming the greater average range of secondary electrons produced in interactions with iodine. Results using the modified versions of the artery model are shown in Figure   6 and Table 2 for Spectrum 1. The impact of various modifications to the artery model are shown in Table 2 and Figure 6 . The narrow lumen, wide lumen, no build-up, 25 cm 2 beam and 100 cm 2 beam modifications resulted in 1%, -3%, 0%, 1% and 1% changes to DEFICM respectively, compared to the original model, with these differences approximately maintained at each distance from the lumen edge. Table 1 for Spectrum 1.
Photoelectric absorption in the blood was increased by a factor of 2.98, 5.01, 22.11 and 44.99 for ρiI levels of 5, 10, 50 and 100 mg/ml, respectively (Spectrum 1), while the number of Compton scattering events was increased by a factor of 1.01, 1.03, 1.10 and 1.18 for the same respective ρiI levels. Knockon electrons were increased by a similar extent to the increase in absorbed dose.
For the capillary model, the DEFICM for the blood was raised to a smaller extent than for the artery model (Table 3) , averaging 1.31, 1.61, 4.29 and 7.97 across the four spectra. The gradient in DEFICM away from the lumen was similar to the artery model, with the enhancement effect falling by around 65% in the first micrometre. The DEFICM for each lattice element as a whole (blood, capillary wall and surrounding tissue) was 86% lower than DEFICM for the blood only. The DEFICM for all extravascular tissues (regions B-G in Figure 2 ) was 48% lower than for the whole element. This implies that if ICM are restricted to capillaries, the impact on dose to extravascular tissues is lower than would be suggested by macroscopic organ dose, assuming a homogenous iodine concentration.
The impact of beam energy was higher than seen for the artery model, with DEFICM being noticeably lower for Spectrum 1 than for other spectra for the blood region (Table 3) .
For the dense capillary model, DEFICM for both the blood and the surrounding tissues was higher, compared to the standard capillary model (Table 4) . For each whole lattice element, DEFICM was 52% lower than for the blood only, viz. a smaller difference than for the standard model. Increasing the density of surrounding soft tissue in regions B-G of the standard capillary model led to a decrease in DEFICM in these regions (Table 5) , ranging from -11% in region B to -68% in region G. Decreasing density led to an increase in DEFICM, ranging from +14% in region B to +110% in region G (Table 5 ).
These findings are consistent with the density of material respectively reducing and increasing the range of secondary electrons released in the capillary lumen. Replacing the soft tissue in regions B-G with adipose tissue resulted in a 5% increase in DEFICM to these regions. Replacing with bone resulted in a 16% decrease in DEFICM to regions B-G and a 52% decrease in DEFICM to the blood. The absorbed dose in the bone is already much higher for these photon energies, making the bone less sensitive to effects happening in adjacent blood vessels. For the model representing cells surrounded by interstitial fluid, the presence of extracellular iodine increased dose to cells (Table 6 ). For an iodine mass concentration of 5 mg/ml, mean DEFICM figures for the nuclei and cell remainders were 1.16 and 1.20 respectively. These figures were around 38% and 23% lower than the DEFICM for the whole lattice element (1.26). Again, this suggests macroscopic organ doses assuming a homogenous distribution of iodine would overestimate ICM-related increase in dose to critical structures (i.e. cell nuclei). Decreasing the cell radii to 6 μm, thereby increasing the extracellular proportion of each element, increased the nucleus DEFICM by approximately 60% compared to the standard interstitial model. Discussion:
A small number of dosimetric evaluations of iodinated contrast media in x-ray imaging have been published. Jost et al [18] calculated the blood dose enhancement factor due to the presence of iodine, based on the ratio of mass attenuation coefficients of blood, and a blood and iodine solution. These DEFICM figures were 1.56 and 6.30, for 5 and 50 mg/ml iodine concentrations, respectively (120 kV CT beam spectrum). These were reasonably similar to our Monte Carlo-derived DEFICM figures for the blood, for Spectrum 1 (the closest match), of 1.63 and 6.94 respectively. Callisen et al [19] calculated DEFICM figures of 1.4, 1.8 and 2.9 for ICM concentrations of 1%, 2% and 5%, respectively (equivalent to 3.7, 7.4 and 18.5 mg I/ml, based on the iodine content of ICM of 370 g/ml). By linearly scaling the results of our study to these iodine concentrations, our equivalent figures were 1.49, 1.98 and 3.45, for Spectrum 4.
Three groups of researchers have investigated the impact of ICM on the absorbed dose to tissues other than the blood, from diagnostic x-ray procedures [6] [7] [8] [9] [10] , albeit with very different approaches. Amato et al [6, 7] estimated the average concentration of iodine within organs, based on the difference in Hounsfield unit (ΔHU) between ICM-enhanced and unenhanced CT scans. These concentrations were then incorporated into GEANT 4 Monte Carlo simulations, yielding estimates for ICM-associated increases in dose to the liver, kidneys, pancreas/spleen and thyroid of 1.19 1.71, 1.33 and 1.41, respectively. A recent study by Sahbaee et al [10] used a pharmacokinetic modelling approach to estimate iodine concentration for a range of abdominal organs, during CT scans. Monte Carlo simulations were then used to estimate an ICM-associated increase in organ dose of between 17% and 54%. The above studies were based on homogeneous iodine distribution within organs. The findings are therefore more applicable to late-phase exposures such as venous phase CT. In reality, a truly homogenous distribution of iodine throughout tissues is unlikely to occur as ICM do not enter cells themselves. Dose enhancement to critical cellular targets (i.e. DNA in extravascular cells) may, therefore, be overestimated to some extent. Sahbaee et al [10] did however, perform a simple microdosimetric analysis to determine the proportion of electron energy deposited outside blood vessels. They reported an ICM-associated increase in 'biologically relevant' dose to the kidneys of 27% while the increase in macroscopic kidney dose was 54%.
The study by He et al [8] assumed iodine was restricted to a single sphere of water, embedded within a larger water sphere, of radius 14 cm, representing the patient. The energy imparted to the 'contrast sphere' was increased by a factor of 2.38, 2.21 and 1.63 at 10 mg/ml iodine concentrations, for contrast sphere diameters of 0.5 cm, 4.0 cm and 16.0 cm (60 keV mono-energetic x-ray beam). The overall energy imparted to the whole phantom was almost unchanged, however. The relative increase in energy imparted to the smallest contrast sphere was very close to the increase in energy imparted to blood in our study of 2.34 (Spectrum 1).
The dose enhancement factors obtained in the current study were also compared to observed increases in blood cell damage foci (lymphocyte γH2AX, dicentrics and survival) reported in serval in vitro studies, cf. [18] [19] [20] [21] . These damage foci were increased by an average factor of 1.28 for ρiI levels between 3.7 and 7.4 mg/ml (range: 0.8-1.7) thus similar to our DEFICM figures in the first 2-3 μm of the vessel wall (i.e. 1.17-1.30). It would be expected that lymphocyte damage enhancement would be somewhat lower than blood dose enhancement due to the separation between DNA molecules and the extracellular environment (ICM does not enter the cells themselves). Lymphocytes have an unusually large nucleus, surrounded by a very thin rim of cytoplasm [22] , meaning lymphocyte DNA may be very close (< 1 μm) to the extracellular environment and ICM molecules. Further research in which lymphocytes are explicitly modelled would be useful.
As ICM do not appear to increase DNA damage when mixed with blood in the absence of irradiation [21, 23, 24] , or are pre-irradiated before mixing [23] , There is reasonably strong evidence that ionising radiation exposure increases the risk of cardiovascular disease (CVD), including among individuals receiving radiotherapy and those occupationally exposed [26, 27] . Significant increases in CVD have been observed down to doses of 0.5 Gy, though lower confidence interval limits often include zero [28] . A number of studies have estimated the mean absorbed dose to the heart following x-ray guided cardiac catheterizations [29] [30] [31] [32] . Vañó et al [29] estimated that 10-17% of diagnostic and therapeutic cardiac fluoroscopy procedures resulted in absorbed doses to the heart of greater than 0.5 Gy. For paediatric procedures, estimated cardiac doses may exceed several hundred mGy for a single procedure [30, 31] or up to 2.9
Gy following multiple procedures [31] . All these studies used the Monte Carlo code PCXMC (STUK, Helsinki, Finland) [33] , which models all internal organs as a uniform soft tissues and does not allow organ composition to be adjusted or allow calculation of dose to substructures within organs. Besides, PCXMC does not simulate electrons, and thus assumes x-ray energy is deposited at the exact site of interaction [33] . We avoided these issues by using MCNP, which can (if instructed) simulate electrons and is not restricted to inbuilt phantom models.
The endothelium has been identified as a critical target in the pathogenesis of radiation induced CVD [28, 34] . This structure, which comprises a single layer of simple squamous cells lining the inside of blood vessels and heart (i.e. the endocardium) [22] , is now regarded as much more than a simple barrier and is recognized as having an important role in many vascular functions [13, 35] . The large increase in dose to the endothelium may, therefore, mean ICM-enhanced exposures have a greater impact on CVD risk than suggested by macroscopic estimates of absorbed dose to the heart.
A number of questions remain unresolved. Firstly, there are little data concerning the concentration of iodine in blood vessels and interstitial fluids at the time of exposure for clinical examinations. Clinical ρiI is likely to be in the range 0-10 mg/ml [9, 10] , though potentially up to 50 mg/ml for direct transcatheter injections [21] . A second issue is the potential compensatory increase in x-ray output by automatic exposure control (AEC) devices following contrast enhancement [5, 11] . There is mixed evidence of a difference in CTDI or DLP for CT scans [23, 24, 36] , though based on limited sample sizes. As CT output is usually based on the unenhanced scout image, an increase in CTDI or DLP ought not to be expected.
In this study, we have assumed only targeted effects of ionisation radiation. So-called bystander effects could, potentially, result in damage to cells not traversed by secondary electrons [37] . This could, in theory, mean damage enhancement effects of ICM could extend further than suggested by modelling physical processes alone. Although bystander signals may cause DNA damage in untraversed cells, the overall impact is currently unknown and therefore difficult to incorporate into microdosimetric models.
Monte Carlo simulation uncertainties were within acceptable limits (i.e. <5%). Systematic 'B-type' uncertainties are more difficult to assess. These include (1) variation between patient tissue composition and the relatively crude models used in this study, and (2) differences between simulated radiation transport in MCNP and real particles. The results of sensitivity analyses using different blood vessel sizes suggest a relatively minor impact on the dose gradient away from the lumen edge (Tables 2). A larger impact was found for changes to soft tissue density and the distance between capillaries (Tables 4 and 5 ). Improved estimates could be obtained by developing more realistic models representing specific tissue types such as lungs, thyroid or bone marrow. Of those, consideration of the bone marrow may prove particularly challenging, given the additional dose enhancement effects arising from the sharp differences in density and effective-Z that occur on the microstructure level at the boundaries between the soft marrow and trabecular bone.
Conclusion:
It has been suggested that iodinated contrast media may increase cancer risks from diagnostic x-ray and interventional fluoroscopy exposures. This study suggests that the impact on cells outside of blood vessels, including those prone to malignant transformation, is likely to be [perhaps grossly] overestimated by assays of blood cell damage and estimates of absorbed dose to the blood, and moderately overestimated by macroscopic organ doses. Conversely, the dose to the endothelium of blood vessels and the heart may be underestimated by macroscopic doses. This may have consequences in terms of the potential for increased risks of radiation-induced health effects such as cardiovascular disease resulting from interventional fluoroscopy procedures. 
